Results 151 to 160 of about 781,343 (307)

Mouse model for interstitial lung disease [PDF]

, 2009

openalex   +1 more source

Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment [PDF]

, 2022
Pierfranco Conté, P.A. Ascierto, Giorgio Patelli, Romano Danesi, Angelo Vanzulli, Fabio Sandomenico, Paolo Tarsia, Anna Maria Cattelan, Alessia Comes, Michelino De Laurentiis, Alfredo Falcone, Daniele Regge, Luca Richeldi, Salvatore Siena   +13 more
openalex   +1 more source

Factors influencing long-term outcomes in fibrotic interstitial lung disease (F-ILD) diagnosed through multidisciplinary discussion (MDD): a prospective cohort study

European Journal of Medical Research
Background The diagnostic process for fibrotic interstitial lung disease (F-ILD) is notably intricate, necessitating a multidisciplinary discussion to achieve consensus based on both clinical and radiological features.
Yu-Wan Liao, Ming-Cheng Liu, Yu-Cheng Wu, Chiann-Yi Hsu, Wen-Nan Huang, Yi-Hsing Chen, Pin-Kuei Fu   +6 more
doaj   +1 more source

Late‐onset noninfectious interstitial lung disease following autologous haematopoietic stem cell transplantation in paediatric patients [PDF]

, 2016
Y.-B. Lee, Rimm Huh, Jihyun Kim, Kangmo Ahn, Ki Woong Sung, Joongbum Cho   +5 more
openalex   +1 more source

Lung transplantation for interstitial lung disease: evolution over three decades [PDF]

, 2023
Swee Wei Leong, Saskia Bos, James Lordan, Arun Nair, Andrew J. Fisher, Gerard Meachery   +5 more
openalex   +1 more source

Patient-centered care in pulmonary fibrosis: access, anticipate, and act

Respiratory Research
Comprehensive care integrates individual patient needs and is highly valued for patients with pulmonary fibrosis (PF). The importance of a patient-centered care approach is rooted in the unpredictable progressiveness of the disease course in PF.
Delian E. Hofman, Tonia Magrì, Catharina C. Moor, Luca Richeldi, Marlies S. Wijsenbeek, Yuko Waseda   +5 more
doaj   +1 more source

Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures [PDF]

, 2022
Marlies Wijsenbeek, María Molina‐Molina, Olivier Chassany, John P. Fox, Liam Galvin, Klaus Geißler, Katherine M. Hammitt, Michael Kreuter, Teng Moua, Emily C. O’Brien, Ashley F. Slagle, Anna Krasnow, Matthew Reaney, Michael Baldwin, Natalia Male, Klaus Röhr, Jeff Swigris, Κατερίνα Αντωνίου   +17 more
openalex   +1 more source

Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease [PDF]

, 2021
Kathleen Biblowitz, Cathryn Lee, Daisy Zhu, Imre Noth, Rekha Vij, Mary E. Strek, Shashi Bellam, Ayodeji Adegunsoye   +7 more
openalex   +1 more source

A combined measure of blood leukocytes, forced vital capacity and quantitative CT is highly predictive of mortality in IPF: results of a single-centre cohort study

BMC Pulmonary Medicine
Background Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic condition. Serial FVC monitoring is most commonly used to assess progression of disease but FVC does not always reflect regional CT change in IPF.
Andrew Achaiah, Emily Fraser, Peter Saunders, Rachel Hoyles, Rachel Benamore, Ling-Pei Ho   +5 more
doaj   +1 more source

Case of periodic disease with recurrent interstitial lung disease

, 2017
A V Shestakova, С. Н. Волкова, G V Shestakova, Мария Лавровна Горбунова, I V D’yachkova, E V Radovskaya   +5 more
openalex   +2 more sources